Oxidative Stress, Synaptic Dysfunction, and Alzheimer’s Disease

Tönnies, Eric, Trushina, Eugenia·2017·Journal of Alzheimer s Disease

Cited by (1,001)

Items 801–900 of 1,001

  1. Association of cigarette smoking with cognitive impairment in male patients with chronic schizophrenia
    Shuochi Wei, Dongmei Wang, Gao‐Xia Wei, Jiesi Wang, Huixia Zhou, Hang Xu, Luyao Xia, Yang Tian, Qilong Dai, Rongrong Zhu et al. · 2020 · Psychopharmacology
  2. Mitohormesis; Potential implications in neurodegenerative diseases
    Dhruv Gohel, Rajesh Kumar Singh · 2020 · Mitochondrion
  3. Ultraviolet A irradiation induces ultraweak photon emission with characteristic spectral patterns from biomolecules present in human skin
    Katsuhiko Tsuchida, Masaki Kobayashi · 2020 · Scientific Reports
  4. Subcommissural Organ-Spondin-Derived Peptide Restores Memory in a Mouse Model of Alzheimer’s Disease
    Juliette Le Douce, Nathalie Delétage, Valérie Bourdès, Sighild Lemarchant, Yann Godfrin · 2021 · Frontiers in Neuroscience
  5. Antiaging activity of polyphenol rich Calophyllum inophyllum L. fruit extract in Saccharomyces cerevisiae BY611 yeast cells
    Venugopal Kavilasha, Sreenivasan Sasidharan · 2021 · Food Bioscience
  6. Comprehensive investigations for a potential natural prophylaxis—A cellular and murine model for apple cider vinegar against hydrogen peroxide and scopolamine induced oxidative stress
    Smriti Tripathi, Papiya Mitra Mazumder · 2021 · Drug Development Research
  7. A combinatorial approach to screen structurally diverse acetylcholinesterase inhibitory plant secondary metabolites targeting Alzheimer’s disease
    Gourav Choudhir, Satyawati Sharma, Puttaswamy Hariprasad · 2021 · Journal of Biomolecular Structure and Dynamics
  8. Simultaneous Determination of Seven Lipophilic and Hydrophilic Components in Salvia miltiorrhiza Bunge by LC-MS/MS Method and Its Application to a Transport Study in a Blood-Brain-Barrier Cell Model
    Hui Wang, Mingyong Zhang, Jiahao Fang, Yuzhen He, Min Liu, Zhanying Hong, Yifeng Chai · 2022 · Molecules
  9. [18F]ROStrace detects oxidative stress in vivo and predicts progression of Alzheimer’s disease pathology in APP/PS1 mice
    Chia‐Ju Hsieh, Catherine Hou, Yi Zhu, Ji Youn Lee, Neha Kohli, Evan P. Gallagher, Kuiying Xu, Hsiaoju S. Lee, Shihong Li, Meagan J. McManus et al. · 2022 · EJNMMI Research
  10. The Rat Brain Transcriptome: From Infancy to Aging and Sporadic Alzheimer’s Disease-like Pathology
    Natalia A. Stefanova, Nataliya G. Kolosova · 2023 · International Journal of Molecular Sciences
  11. A Novel Polysaccharide DSPP-1 from Durian Seed: Structure Characterization and Its Protective Effects Against Alzheimer’s Disease in a Transgenic Caenorhabditis elegans Model
    Chuxiang Xiao, Tiejun Chen, Meng Yuan, Yu Li, Fengwu Wang · 2023 · Plant Foods for Human Nutrition
  12. Evidence That Increasing Serum 25(OH)D Concentrations to 30 ng/mL in the Kingdom of Saudi Arabia and the United Arab Emirates Could Greatly Improve Health Outcomes
    William Burgess Grant, Fatme Al Anouti, Barbara Joan Boucher, Hana M. A. Fakhoury, Meis Moukayed, Stefan Pilz, Nasser M. Al‐Daghri · 2023 · Biomedicines
  13. Role of TPEN in Amyloid-β25–35-Induced Neuronal Damage Correlating with Recovery of Intracellular Zn2+ and Intracellular Ca2+ Overloading
    Wenbo Chen, Yuxiang Wang, Hong‐Gang Wang, Di An, Dan Sun, Pan Li, Tao Zhang, Wange Lu, Yan‐qiang Liu · 2023 · Molecular Neurobiology
  14. Exploring the significance of lipids in Alzheimer's disease and the potential of extracellular vesicles
    Huaqi Su, Colin Louis Masters, Ashley Ian Bush, Kevin Jeffrey Barnham, Gavin E. Reid, Laura J. Vella · 2023 · PROTEOMICS
  15. The structurally diverse phytocannabinoids cannabichromene, cannabigerol and cannabinol significantly inhibit amyloid β‐evoked neurotoxicity and changes in cell morphology in PC12 cells
    Dylan T. Marsh, Ayato Sugiyama, Yuta Imai, Ryuji Kato, Scott Darryl Smid · 2023 · Basic & Clinical Pharmacology & Toxicology
  16. Extract of Cynomorium songaricum ameliorates mitochondrial ultrastructure impairments and dysfunction in two different in vitro models of Alzheimer’s disease
    Dan Cheng, Lei Su, Xu Wang, Xinjie Li, Lingling Li, Mengyuan Hu, Yi Lu · 2021 · BMC Complementary Medicine and Therapies
  17. SQSTM1/p62 Post-Translational Modifications and Reverse Processes Modulate Disease Pathogenesis via KEAP1-NRF2 Signaling and Selective Autophagy
    Dong‐Rong Zhu, Yue Li, Lirong Zhao, Duxiang Pei, Yutong Guo, Liren Liu · 2025 · Antioxidants and Redox Signaling
  18. Nacre extract from pearl oyster attenuates amyloid beta-induced memory impairment
    Yamato Yotsuya, Yasushi Hasegawa · 2022 · Journal of Natural Medicines
  19. Single-neuron whole genome sequencing identifies increased somatic mutation burden in Alzheimer's disease related genes
    Zongchang Li, Shishi Min, Ney Alliey‐Rodriguez, Gina M. Giase, Lijun Cheng, David Wesley Craig, Geoffrey J. Faulkner, Huma Asif, Chunyu Liu, Elliot S. Gershon · 2022 · Neurobiology of Aging
  20. An Investigation into the Effects of Water- and Fat-Soluble Vitamins in Alzheimer's and Parkinson's Diseases
    Mohammad Hasan Shahverdi, Zahra Sourani, Marzieh Sargolzaie, Mostafa Modarres Mousavi, Behnam Bakhtiari Moghadam, Sadegh Shirian · 2023 · The Neuroscience Journal of Shefaye Khatam
  21. A Standardized Extract of Microalgae Phaeodactylum tricornutum (Mi136) Inhibit D-Gal Induced Cognitive Dysfunction in Mice
    Jonathan Maury, Antoine Delbrut, Vanessa Villard, Rémi Pradelles · 2024 · Marine Drugs
  22. Brain Mitochondria as a Therapeutic Target for Carnosic Acid
    Vittoria Infantino, Ilaria Pappalardo, Anna Santarsiero, Swapnil Tripathi, Gyanendra Singh, Marcos Roberto de Oliveira · 2024 · Journal of Integrative Neuroscience
  23. Another Use for a Proven Drug: Experimental Evidence for the Potential of Artemisinin and Its Derivatives to Treat Alzheimer’s Disease
    Éva Kiss, Stefan Kins, Karin Gorgas, Kinga Hajnal Venczel Szakács, Joachim Kirsch, Jochen Kuhse · 2024 · International Journal of Molecular Sciences
  24. A novel neuroprotective peptide YVYAETY identified and screened from Flammulina velutipes protein hydrolysates attenuates scopolamine-induced cognitive impairment in mice
    Yutong Dong, Qiuhui Hu, Liyan Zhao, Gaoxing Ma, Ning Ma, Junmiao Zhang, Yang Ji, Li Liu · 2024 · Food & Function
  25. Mitochondrial alterations in fibroblasts from sporadic Alzheimer's disease (AD) patients correlate with AD-related clinical hallmarks
    Fanny Eysert, Paula Fernanda Kinoshita, Julien Lagarde, Sandra Lacas‐Gervais, Laura Xicota, Guillaume Dorothée, Michel Bottlaender, Frédéric Checler, Marie‐Claude Potier, Marie Sarazin et al. · 2024 · Acta Neuropathologica Communications
  26. Exposure to coal dust exacerbates cognitive impairment by activating the IL6/ERK1/2/SP1 signaling pathway
    Fulin Cai, Sheng Xue, Zan Zhou, Xin Zhang, Yingjie Kang, Jing Zhang, Mei Zhang · 2024 · The Science of The Total Environment
  27. A comprehensive update on cannabidiol, its formulations and drug delivery systems
    Surojit Banerjee, Vikas Anand Saharan, Debadri Banerjee, Veerma Ram, Hitesh Kulhari, Deep Pooja, Anupama Singh · 2024 · Phytochemistry Reviews
  28. Electroacupuncture activates AMPKα1 to improve learning and memory in the APP/PS1 mouse model of early Alzheimer’s disease by regulating hippocampal mitochondrial dynamics
    Weiwei Jia, Huawei Lin, Minguang Yang, Ya-ling Dai, Yanyi Ding, Wen-shan Xu, Si-nuo Wang, Yajun Cao, Shengxiang Liang, Zhifu Wang et al. · 2024 · Journal of Chinese Integrative Medicine
  29. Exploring Cimetidine as a Potential Therapeutic Attenuator against Amyloid Formation in Parkinson’s Disease: Spectroscopic and Microscopic Insights into Alpha-Synuclein and Human Insulin
    Md Nadir Hassan, Azeem Ahmad, Murtaza Shabbir Hussain, Suhani Gupta, Huzaifa Yasir Khan, Tariq Aziz, Rizwan Hasan Khan · 2024 · ACS Chemical Neuroscience
  30. Associations of Spatial Disparities of Alzheimer’s Disease Mortality Rates with Soil Selenium and Sulfur Concentrations and Four Common Risk Factors in the United States
    Hongbing Sun · 2017 · Journal of Alzheimer s Disease
  31. A multistationary loop model of ALS unveils critical molecular interactions involving mitochondria and glucose metabolism
    Bruno Burlando, Marco Milanese, Giulia Giordano, Tiziana Bonifacino, Silvia Ravera, Franco Blanchini, Giambattista Bonanno · 2020 · PLoS ONE
  32. The Role of Equilibrium between Free Radicals and Antioxidants in Depression and Bipolar Disorder
    Anastasia Kotzaeroglou, Ioannis Tsamesidis · 2022 · Medicines
  33. Traversing through the cell signaling pathways of neuroprotection by betanin: therapeutic relevance to Alzheimer’s Disease and Parkinson’s Disease
    Banashree Chetia Phukan, Rubina Roy, Rajib Kumar Paul, Muhammed Khairujjaman Mazumder, Joyobrato Nath, Pallab Bhattacharya, Anupom Borah · 2023 · Metabolic Brain Disease
  34. Exploring the potential of mindfulness-based therapy in the prevention and treatment of neurodegenerative diseases based on molecular mechanism studies
    Congcong Wu, Yue Feng · 2023 · Frontiers in Neuroscience
  35. Serum ischaemia‐modified albumin might be a potential biomarker for oxidative stress in amnestic mild cognitive impairment
    Lei Du, Jianhua Ma, Dan He, Xiaoning Zhang · 2018 · Psychogeriatrics
  36. Timing Matters: Circadian Effects on Energy Homeostasis and Alzheimer’s Disease
    Aline Loehfelm, Alisa Boucsein, Dominik Pretz, Alexander Tups · 2018 · Trends in Endocrinology and Metabolism
  37. Inhibitory effects of curcumin on H2O2-induced cell damage and APP expression and processing in SH-SY5Y cells transfected with APP gene with Swedish mutation
    Xijun Song, He-Yan Zhou, Yaxuan Sun, Han‐Chang Huang · 2020 · Molecular Biology Reports
  38. Luteolin Protects Pheochromocytoma (PC‐12) Cells against Aβ25-35‐Induced Cell Apoptosis through the ER/ERK/MAPK Signalling Pathway
    Han-Rui Wang, Siying Pei, Dongxu Fan, Yan‐Hui Liu, Xiaofeng Pan, Fan‐Xu Song, Shuhua Deng, Hongbin Qiu, Ning Zhang · 2020 · Evidence-based Complementary and Alternative Medicine
  39. Isoliquiritigenin attenuated cognitive impairment, cerebral tau phosphorylation and oxidative stress in a streptozotocin-induced mouse model of Alzheimer's disease
    Zhi Tang, Ting Sha, Yuanshang Wang, Yan Chun Xiao, Yuanting Ding, Ruiqing Ni, Xiaolan Qi · 2025 · Life Sciences
  40. Impairment of Tricarboxylic Acid Cycle (TCA) Cycle in Alzheimer's Disease: Mechanisms, Implications, and Potential Therapies
    Gudimetla Susmitha Mohan, Rahul Kumar · 2025 · Aging and Disease
  41. Tortoise Plastron and Deer Antler Gelatin Prevents Against Neuronal Mitochondrial Dysfunction In Vitro: Implication for a Potential Therapy of Alzheimer’s Disease
    Dan Cheng, Xinjing Yang, Lu Zhang, Zongshi Qin, Wenqi Li, Hai-Chun Xu, Zhang‐Jin Zhang · 2021 · Frontiers in Pharmacology
  42. Novel Lawsone–Quinoxaline Hybrids as New Dual Binding Site Acetylcholinesterase Inhibitors
    Paptawan Suwanhom, Teerapat Nualnoi, Pasarat Khongkow, Varomyalin Tipmanee, Luelak Lomlim · 2023 · ACS Omega
  43. Network pharmacology and in vivo studies reveal the neuroprotective effects of paeoniflorin on Alzheimer's disease
    Mengyuan Zhang, Haoran Zheng, Jiale He, Mei Zhang · 2023 · Heliyon
  44. Oligosaccharides from black ginseng innovatively prepared by low‐temperature steam‐heating process ameliorate cognitive impairment in Alzheimer's disease mice via the Keap‐1/Nrf2 pathway
    Weiyin Xu, Peng Yu, Simeng Shao, Zhaoyang Xie, Yi Wu, Jianing Liu, Tianyang Xu, Guangzhi Cai, Hongmei Yang · 2024 · Journal of the Science of Food and Agriculture
  45. Oral Administration of Euonymus alatus Leaf Extract Ameliorates Alzheimer’s Disease Phenotypes in 5xFAD Transgenic Mice
    Yoonsu Kim, Minjung Cho, Chan Ho Jang, Jeong Lee, Jong‐Sang Kim, Jisun Oh, Jinkyu Lim · 2024 · Foods
  46. Multitarget action of Benzothiazole-piperazine small hybrid molecule against Alzheimer's disease: In silico, In vitro, and In vivo investigation
    Chandra Bhushan Mishra, Shruti Shalini, Siddharth Gusain, Pawan Kumar, Shikha Kumari, Yong-Sung Choi, Jyoti Kumari, Balakrishna Moku, Anita Kumari Yadav, Amresh Prakash et al. · 2024 · Biomedicine & Pharmacotherapy
  47. Dendrimers—Novel Therapeutic Approaches for Alzheimer’s Disease
    Mroziak, Magdalena, Kozłowski, Gracjan, Kołodziejczyk, Weronika, Pszczołowska, Magdalena, Walczak, Kamil, Beszłej, Jan Aleksander, Leszek, Jerzy · 2024 · Biomedicines
  48. Safflower yellow alleviates cognitive impairment in mice by modulating cholinergic system function, oxidative stress, and CREB/BDNF/TrkB signaling pathway
    Yanqiang Qi, Yanyou Wang, Mingyue Ni, Yingxi He, Le Li, Yanli Hu · 2024 · Journal of Ethnopharmacology
  49. Mitochondria-targeting by small molecules against Alzheimer's disease: A mechanistic perspective
    Chinmay Pal · 2024 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
  50. Advancements in nose-to-brain drug targeting for Alzheimer’s disease: a review of nanocarriers and clinical insights
    Kumari Komal, Rashmi Ghosh, Debayan Sil, Rohit Sharma, Sourabh Kumar, Prachi Pandey, Manish Kumar · 2025 · Inflammopharmacology
  51. Human serum albumin-3-amino-1-propanesulfonic acid conjugate inhibits amyloid-β aggregation and mitigates cognitive decline in Alzheimer's disease
    Divya Shastri, Chaitany Jayprakash Raorane, Vinit Raj, Sang-Kil Lee · 2025 · Journal of Controlled Release
  52. Oxidative Stress in Elderly with Different Cognitive Status: My Mind Project
    Patrizia Fattoretti, Marco Malavolta, Paolo Fabbietti, Roberta Papa, Robertina Giacconi, Laura Costarelli, Roberta Galeazzi, Cristina Paoloni, Demetrio Postacchini, Fabrizia Lattanzio et al. · 2018 · Journal of Alzheimer s Disease
  53. High KEAP1, NRF2 and low HO-1 Serum Levels in Children with Autism
    Hamza Ayaydın, İsmail Akaltun, İsmail Koyuncu, Hakim Çelık, Adnan Kirmit, Hatice TAKATAK · 2020 · Nöro Psikiyatri Arşivi
  54. Sigma ligands as potent inhibitors of Aβ and AβOs in neurons and promising therapeutic agents of Alzheimer's disease
    Wenhui Ma, Ai-Fang Chen, Xiaoyang Xie, Yun‐Sheng Huang · 2020 · Neuropharmacology
  55. A review of antioxidant and anti-acetylcholinesterase activities of Centella asiatica (L.) Urb. for the treatment of Alzheimer’s disease
    S. Abbas, M.S. Latif, N.S. Shafie, M.I. Ghazali, Nurul Alyani Zainol Abidin, M.K. Mustafa, Faridah Bt Kormin · 2021 · Food Research
  56. Cholinergic drugs bind at the minor groove and reverse induced oxidative stress of calf thymus DNA: a new perspective towards an unexplored therapeutic efficacy
    Prayasee Baruah, Pynskhemborlang T. Phanrang, Ibemhanbi Konthoujam, Kripamoy Aguan, Sivaprasad Mitra · 2021 · New Journal of Chemistry
  57. Effect of APOE ε4 allele on levels of apolipoproteins E, J, and D, and redox signature in circulating extracellular vesicles from cognitively impaired with no dementia participants converted to Alzheimer's disease
    Mohamed Raâfet Ben Khedher, Mohamed Haddad, Danielle Laurin, Charles Ramassamy · 2021 · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring
  58. Phytochemical investigations, antioxidant, cytotoxic, antidiabetic and antibiofilm activities of Kalanchoe laxiflora flowers
    Ezzat E.A. Osman, Asmaa Shams El Dein Mohamed, Ahmed Elkhateeb, Gobouri Adil, Marwa M. Abdel‐Aziz, El-Sayed Saleh Abdel-Hameed · 2021 · European Journal of Integrative Medicine
  59. Protective effects of Vinca herbaceous extract against scopolamine-induced behavioral disturbances and brain oxidative stress in rats
    Mir‐Jamal Hosseini, Niloofar Mahmoodi, Javad Eskandari, Soroush Bijani, Alireza Yazdinezhad, Mahdieh Anoush · 2022 · Heliyon
  60. Deletion of Wnt10a Is Implicated in Hippocampal Neurodegeneration in Mice
    Jia-He Zhang, Takashi Tasaki, Manabu Tsukamoto, Ke‐Yong Wang, Kin‐ya Kubo, Kagaku Azuma · 2022 · Biomedicines
  61. Deregulation of Mitochondrial Calcium Handling Due to Presenilin Loss Disrupts Redox Homeostasis and Promotes Neuronal Dysfunction
    Kerry C. Ryan, Jocelyn T. Laboy, Kenneth R. Norman · 2022 · Antioxidants
  62. Targeting Novel microRNAs in Developing Novel Alzheimer's Disease Treatments
    Fatemehsadat Seyedaghamiri, Mojgan Rajabi, Gisou Mohaddes · 2022 · Neurochemical Research
  63. MicroRNA-668-3p regulates oxidative stress and cell damage induced by Aβ1-42 by targeting the OXR1/p53-p21 axis
    Shengyu Li, Lishuo Wu, Meigang Ma, Long-Xiu Yang, Chao Qin · 2022 · Annals of Translational Medicine
  64. Structurally Altered, Not Wild-Type, Pentameric C-Reactive Protein Inhibits Formation of Amyloid-β Fibrils
    Donald Neba Ngwa, Alok Agrawal · 2022 · The Journal of Immunology
  65. Lycopene: Sojourn from kitchen to an effective therapy in Alzheimer's disease
    Bhupinder Kapoor, Monica Gulati, Pooja Rani, Rajpal Singh Kochhar, Atanas G. Atanasov, Reena Gupta, Deepika Sharma, Deepak N. Kapoor · 2022 · BioFactors
  66. Muscular Swedish mutant APP-to-Brain axis in the development of Alzheimer’s disease
    Jin‐Xiu Pan, Daehoon Lee, Dong Sun, Kai Zhao, Lei Xiong, Hao-Han Guo, Xiao Ren, Peng Chen, Raquel López de Boer, Yuyi Lu et al. · 2022 · Cell Death and Disease
  67. Unexpected Classes of Aquaporin Channels Detected by Transcriptomic Analysis in Human Brain Are Associated with Both Patient Age and Alzheimer’s Disease Status
    Zein Amro, Matthew Ryan, Lyndsey E. Collins‐Praino, Andrea J. Yool · 2023 · Biomedicines
  68. Rewiring of neuronal networks during synaptic silencing
    Jana Katharina Dahlmanns, Vicky von Einem, Katharina Breininger, Marc Dahlmanns, Andreas Maier, Johannes Kornhuber, Teja Wolfgang Groemer · 2017 · Scientific Reports
  69. A Synthetic Pro-Drug Peptide Reverses Amyloid-β-Induced Toxicity in the Rat Model of Alzheimer’s Disease
    Sourav Kumar, Saurabh Srivastav, Mahino Fatima, Rajat Subhra Giri, Bhubaneswar Mandal, Amal Chandra Mondal · 2019 · Journal of Alzheimer s Disease
  70. Cerebrospinal fluid oxidative stress markers in Alzheimer's disease
    Ryuji Sakakibara, Takayuki Kawai · 2020 · Neurology and Clinical Neuroscience
  71. The potential role of nanoyttria in alleviating oxidative stress biomarkers: Implications for Alzheimer's disease therapy
    Kim San Tang · 2020 · Life Sciences
  72. Upregulation of Prickle2 Ameliorates Alzheimer’s Disease-Like Pathology in a Transgenic Mouse Model of Alzheimer’s Disease
    Feng-Xian Sun, Fang Jiang, Na Zhang, Hua Li, Weiping Tian, Weiying Liu · 2020 · Frontiers in Cell and Developmental Biology
  73. Mitochondrial TXN2 attenuates amyloidogenesis via selective inhibition of BACE1 expression
    Kunyi Li, Xiaojiao Xiang, Song Li, Jian Chen, Biao Luo, Qi‐Xin Wen, Bi‐Rou Zhong, Gui‐Feng Zhou, Xiaojuan Deng, Yuanlin Ma et al. · 2020 · Journal of Neurochemistry
  74. Early detection of redox imbalance in the APPswe/PS1dE9 mouse model of Alzheimer’s disease by in vivo electron paramagnetic resonance imaging
    Miho C. Emoto, Hideo Sato‐Akaba, Naoya Hamaue, Katsuya Kawanishi, Hisashi Koshino, Shun Shimohama, Hirotada G. Fujii · 2021 · Free Radical Biology and Medicine
  75. Sulforaphane inhibits the production of Aβ partially through the activation of Nrf2-regulated oxidative stress
    Shunxi Zhang, Jiahe Zhao, Zhihuai Bai, Lina Luo, Fan Wu, Bao‐Long Li, Yujuan Shan · 2021 · Food & Function
  76. Astrocyte Circadian Timekeeping in Brain Health and Neurodegeneration
    Marco Brancaccio, Anne C. Wolfes, Natalie Ness · 2021 · Advances in experimental medicine and biology
  77. Rutin ameliorates scopolamine-induced learning and memory impairments through enhancement of antioxidant defense system and cholinergic signaling
    Ismail Ogunbayode Ishola, Taiwo Grace Olubodun-Obadun, Mariam A. Ojulari, Olufunmilayo Olaide Adeyemi · 2020 · Drug metabolism and drug interactions
  78. Beyond the classical amyloid hypothesis in Alzheimer's disease: Molecular insights into current concepts of pathogenesis, therapeutic targets, and study models
    Atsadang Theerasri, Sakawrat Janpaijit, Tewin Tencomnao, Anchalee Prasansuklab · 2022 · WIREs Mechanisms of Disease
  79. Systemic Metabolism and Mitochondria in the Mechanism of Alzheimer’s Disease: Finding Potential Therapeutic Targets
    Song, Meiying, Fan, Xiang · 2023 · International Journal of Molecular Sciences
  80. Deciphering the links between psychological stress, depression, and neurocognitive decline in patients with Down syndrome
    François Poumeaud, Clotilde Mircher, Peter J. K. Smith, Pierre-Antoine Faye, Franck G. Sturtz · 2021 · Neurobiology of Stress
  81. Action of the Purinergic and Cholinergic Anti-inflammatory Pathways on Oxidative Stress in Patients with Alzheimer’s Disease in the Context of the COVID-19 Pandemic
    Júlia Leão Batista Simões, Leilane Dayane Sobierai, Inayá Flores Leal, Miriam Vitória Rodrigues dos Santos, João Victor Coiado, Margarete Dulce Bagatini · 2022 · Neuroscience
  82. Hippocampal metabolic subregions and networks: Behavioral, molecular, and pathological aging profiles
    Somayeh Maleki Balajoo, Simon Bodo Eickhoff, Shahrzad Kharabian Masouleh, Anna Plachti, Laura K. Waite, Amin Saberi, Mohamed Ali Bahri, Christine Bastin, Éric Salmon, Felix Hoffstaedter et al. · 2023 · Alzheimer s & Dementia
  83. Protocol Report on the Transcranial Photobiomodulation for Alzheimer’s Disease (TRAP-AD) Study
    Dan Vlad Iosifescu, Xiaotong Song, Maia Beth Gersten, Arwa Adib, Yoonju Cho, Katherine Anne Collins, Kathy F. Yates, Aura Maria Hurtado Puerto, Kayla Marie McEachern, Ricardo S. Osorio et al. · 2023 · Healthcare
  84. Identification of Uncaria rhynchophylla in the Potential Treatment of Alzheimer’s Disease by Integrating Virtual Screening and In Vitro Validation
    Shuang Jiang, Gilwa Borjigin, Jiahui Sun, Qi Li, Qianbo Wang, Yuanqiu Mu, Xuepeng Shi, Qian Li, Xiaotong Wang, Xiaodan Song et al. · 2023 · International Journal of Molecular Sciences
  85. Age-induced nitrative stress decreases retrograde transport of proNGF via TrkA and increases proNGF retrograde transport and neurodegeneration via p75NTR
    Erika Kropf, Arman Shekari, Sama Jaberi, Anish Puri, Chengbiao Wu, Margaret L. Fahnestock · 2023 · Frontiers in Molecular Neuroscience
  86. Amyloid‑β guided responsive theranostic fluorescent probe for imaging of endogenous hydrogen peroxide in Alzheimer disease
    Yuncong Yang, Chengke Wang, Huanxin Xue, Pinyou Chen, Hung‐Wing Li, Man Shing Wong · 2024 · Sensors and Actuators B Chemical
  87. Analytical Methods and Effects of Bioactive Peptides Derived from Animal Products: A Mini-Review
    Jae Won Jeong, Seung Yun Lee, Da Young Lee, Jae Hyeon Kim, Seung Hyeon Yun, Juhyun Lee, Ermie Mariano, Sung‐Sil Moon, Sun Jin Hur · 2024 · Food Science of Animal Resources
  88. Effects of Cycloastragenol on Alzheimer's Disease in Rats by Reducing Oxidative Stress, Inflammation, and Apoptosis
    Kadi M. Alharbi, Shahad Amer Alshehri, Wasayf A Almarwani, Khulud Aljohani, Ajwan Z Albalawi, Areej S. Alatawi, Shekha M. Al-Atwi, Lama S. Alhwyty, Hanan M. Hassan, Mohammed M.H. Al-Gayyar · 2024 · Current Alzheimer Research
  89. The relation of synaptic biomarkers with Aβ, tau, glial activation, and neurodegeneration in Alzheimer’s disease
    Yi-Ting Wang, Nicholas James Ashton, Stijn Servaes, Johanna Nilsson, Marcel S. Woo, Tharick Ali Pascoal, Cécile Tissot, Nesrine Rahmouni, Joseph Therriault, Firoza Zubeida Lussier et al. · 2024 · Translational Neurodegeneration
  90. The neuroprotective role of celastrol on hippocampus in diabetic rats by inflammation restraint, insulin signaling adjustment, Aβ reduction and synaptic plasticity alternation
    Qiaofeng Zhou, Xiying Guo, Tu Chen, Yumin Liu, Huimin Ji, Yixuan Sun, Xiaosong Yang, Changhan Ouyang, Xiufen Liu, Min Lei · 2024 · Biomedicine & Pharmacotherapy
  91. Neuroprotective Effect of Codonopsis pilosula Polysaccharide on Aβ25-35-Induced Damage in PC12 Cells via the p38MAPK Signaling Pathways
    Yang Liu, Shiyi Song, Xinlu Li, Jinquan Wang, Yanan Bao, Xinxin Wang, Liwei Lian, Xiubo Liu, Wei Ma · 2024 · Pharmaceuticals
  92. Role of organometallic complexes in targeted therapies of different diseases: Infectious diseases, Cancer and Neurodegenerative Diseases
    N. V, T. Anand, Chandra Kant Singh, K. K. Sodhi · 2024 · Journal of Organometallic Chemistry
  93. Mitochondria-targeting Cu2-xSe-TPP with dual enzyme activity alleviates Alzheimer's disease by modulating oxidative stress
    Liqiang Wang, Xiaoyu Yuan, Qianyu Cai, Yutong Chen, Zhi Jia, Qiongmei Mai, Jie Liu, Yanan Liu · 2024 · Colloids and Surfaces B Biointerfaces
  94. Defining Alzheimer’s Disease through Proteomic CSF Profiling
    Carmen Peña‐Bautista, Lourdes Álvarez‐Sánchez, Ángel Balaguer, Luis Raga, Lorena García, Miguel Baquero, Consuelo Cháfer‐Pericás · 2024 · Journal of Proteome Research
  95. An endophenotype network strategy uncovers YangXue QingNao Wan suppresses Aβ deposition, improves mitochondrial dysfunction and glucose metabolism
    Xue Wang, Jinna Yang, Xiaolian Zhang, Jinyong Cai, Jieqi Zhang, Chuipu Cai, Yue Zhuo, Shuhuan Fang, Xinxin Xu, Hui Wang et al. · 2024 · Phytomedicine
  96. Mitochondrial Network Branching Enables Rapid Protein Spread with Slower Mitochondrial Dynamics
    Prabha Chuphal, Jordan D. Lanctôt, Sean P. Cornelius, Aidan I. Brown · 2024 · PRX Life
  97. Cellular Uptake of Tau Aggregates Triggers Disulfide Bond Formation in Four-Repeat Tau Monomers
    Brad J. Krzesinski, Tyler J. Holub, Zachariah Y. Gabani, Martin Margittai · 2024 · ACS Chemical Neuroscience
  98. Sodium Thiosulfate: An Innovative Multi-Target Repurposed Treatment Strategy for Late-Onset Alzheimer’s Disease
    Melvin Ray Hayden, Neetu Tyagi · 2024 · Pharmaceuticals
  99. Nanotechnology in Parkinson’s Disease: overcoming drug delivery challenges and enhancing therapeutic outcomes
    Irfan Ali, Mohammad Adil, Mohammad Imran, Saba Asif Qureshi, Saima Qureshi, Nazeer Hasan, Farhan Jalees Ahmad · 2025 · Drug Delivery and Translational Research
  100. Xanthine Oxidoreductase: A Double-Edged Sword in Neurological Diseases
    Massimo Bortolotti, Letizia Polito, Maria Giulia Battelli, Andrea Bolognesi · 2025 · Antioxidants